Literature DB >> 9196512

Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis.

S Walter1, P Gudowius, J Bosshammer, U Römling, H Weissbrodt, W Schürmann, H von der Hardt, B Tümmler.   

Abstract

BACKGROUND: The source of airway colonisation with Pseudomonas aeruginosa is not well defined in patients with cystic fibrosis after lung transplantation. Using a DNA-based typing system a study was undertaken to investigate whether lung transplant recipients acquired new strains of P aeruginosa or retained those they had before transplantation.
METHODS: Seventy four P aeruginosa isolates taken before and after transplantation were analysed from 11 patients with cystic fibrosis who had undergone lung transplantation in the Medical School of Hannover between 1988 and 1994. The genetic relatedness of the 74 P aeruginosa strains was evaluated from macrorestriction fragment pattern similarity.
RESULTS: Each of the 11 lung transplant recipients harboured one identical P aeruginosa clone before and after transplantation. The airways of four of the 11 patients were preoperatively colonised by two or three different clones, but six months after transplantation only one clone was detectable.
CONCLUSIONS: These results show that there is no change in the P aeruginosa population in the airways of lung transplant recipients before and after transplantation and it is assumed that the chronic drainage of P aeruginosa into the lung allografts is caused by the bacterial reservoir in the paranasal sinuses and the trachea.

Entities:  

Mesh:

Year:  1997        PMID: 9196512      PMCID: PMC1758546          DOI: 10.1136/thx.52.4.318

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Mucociliary function after lung transplantation.

Authors:  S Shankar; L Fulsham; R C Read; S Theodoropoulos; P J Cole; B Madden; M Yacoub
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Bacterial reservoirs in cystic fibrosis.

Authors:  C J Taylor; J McGaw; R Howden; B I Duerden; P S Baxter
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

3.  Diagnosing bacterial respiratory infection by bronchoalveolar lavage.

Authors:  F W Kahn; J M Jones
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

4.  Bronchoalveolar lavage for diagnosing acute bacterial pneumonia.

Authors:  J E Thorpe; R P Baughman; P T Frame; T A Wesseler; J L Staneck
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  Intermediate-term results of heart-lung transplantation for cystic fibrosis.

Authors:  B P Madden; M E Hodson; V Tsang; R Radley-Smith; A Khaghani; M Y Yacoub
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

6.  Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats.

Authors:  K D Schmidt; B Tümmler; U Römling
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

Review 7.  Headaches and sinus disease: the endoscopic approach.

Authors:  H Stammberger; G Wolf
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1988 Sep-Oct

8.  Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation.

Authors:  D T Umetsu; R B Moss; V V King; N J Lewiston
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

9.  Abnormal ion permeation through cystic fibrosis respiratory epithelium.

Authors:  M R Knowles; M J Stutts; A Spock; N Fischer; J T Gatzy; R C Boucher
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

10.  Possible insertion sequences in a mosaic genome organization upstream of the exotoxin A gene in Pseudomonas aeruginosa.

Authors:  A E Pritchard; M L Vasil
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.476

View more
  19 in total

1.  Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience.

Authors:  Domenic Vital; Markus Hofer; Annette Boehler; David Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-30       Impact factor: 2.503

Review 2.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 3.  Prevention of chronic rejection after lung transplantation.

Authors:  Anke Van Herck; Stijn E Verleden; Bart M Vanaudenaerde; Geert M Verleden; Robin Vos
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 4.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

5.  Atg7 Deficiency Intensifies Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis.

Authors:  Qinqin Pu; Changpei Gan; Rongpeng Li; Yi Li; Shirui Tan; Xuefeng Li; Yuquan Wei; Lefu Lan; Xin Deng; Haihua Liang; Feng Ma; Min Wu
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

6.  Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis.

Authors:  Catherine R Armbruster; Christopher W Marshall; Arkadiy I Garber; Jeffrey A Melvin; Anna C Zemke; John Moore; Paula F Zamora; Kelvin Li; Ian L Fritz; Christopher D Manko; Madison L Weaver; Jordan R Gaston; Alison Morris; Barbara Methé; William H DePas; Stella E Lee; Vaughn S Cooper; Jennifer M Bomberger
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

7.  Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.

Authors:  R Somayaji; B Waddell; M L Workentine; M G Surette; N P Brager; H R Rabin; M D Parkins
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317

8.  Practical guidelines: lung transplantation in patients with cystic fibrosis.

Authors:  T O Hirche; C Knoop; H Hebestreit; D Shimmin; A Solé; J S Elborn; H Ellemunter; P Aurora; M Hogardt; T O F Wagner
Journal:  Pulm Med       Date:  2014-03-30

9.  Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study.

Authors:  Jochen G Mainz; Katja Schädlich; Claudia Schien; Ruth Michl; Petra Schelhorn-Neise; Assen Koitschev; Christiane Koitschev; Peter M Keller; Joachim Riethmüller; Baerbel Wiedemann; James F Beck
Journal:  Drug Des Devel Ther       Date:  2014-02-10       Impact factor: 4.162

10.  Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.

Authors:  H Al-Momani; A Perry; C J Stewart; R Jones; A Krishnan; A G Robertson; S Bourke; S Doe; S P Cummings; A Anderson; T Forrest; S M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.